495 related articles for article (PubMed ID: 25701309)
21. Physiological roles of asialoglycoprotein receptors (ASGPRs) variants and recent advances in hepatic-targeted delivery of therapeutic molecules via ASGPRs.
Hu J; Liu J; Yang D; Lu M; Yin J
Protein Pept Lett; 2014; 21(10):1025-30. PubMed ID: 24975671
[TBL] [Abstract][Full Text] [Related]
22. Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor.
Sanhueza CA; Baksh MM; Thuma B; Roy MD; Dutta S; Préville C; Chrunyk BA; Beaumont K; Dullea R; Ammirati M; Liu S; Gebhard D; Finley JE; Salatto CT; King-Ahmad A; Stock I; Atkinson K; Reidich B; Lin W; Kumar R; Tu M; Menhaji-Klotz E; Price DA; Liras S; Finn MG; Mascitti V
J Am Chem Soc; 2017 Mar; 139(9):3528-3536. PubMed ID: 28230359
[TBL] [Abstract][Full Text] [Related]
23. Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development.
Li Y; Huang G; Diakur J; Wiebe LI
Curr Drug Deliv; 2008 Oct; 5(4):299-302. PubMed ID: 18855599
[TBL] [Abstract][Full Text] [Related]
24. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
Managit C; Kawakami S; Yamashita F; Hashida M
J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
[TBL] [Abstract][Full Text] [Related]
25. Glycomimetic ligands for the human asialoglycoprotein receptor.
Mamidyala SK; Dutta S; Chrunyk BA; Préville C; Wang H; Withka JM; McColl A; Subashi TA; Hawrylik SJ; Griffor MC; Kim S; Pfefferkorn JA; Price DA; Menhaji-Klotz E; Mascitti V; Finn MG
J Am Chem Soc; 2012 Feb; 134(4):1978-81. PubMed ID: 22280495
[TBL] [Abstract][Full Text] [Related]
26. The unsialylated subpopulation of recombinant activated factor VII binds to the asialo-glycoprotein receptor (ASGPR) on primary rat hepatocytes.
Seested T; Nielsen HM; Christensen EI; Appa RS
Thromb Haemost; 2010 Dec; 104(6):1166-73. PubMed ID: 20886190
[TBL] [Abstract][Full Text] [Related]
27. Effective hepatocyte transplantation using rat hepatocytes with low asialoglycoprotein receptor expression.
Ise H; Nikaido T; Negishi N; Sugihara N; Suzuki F; Akaike T; Ikeda U
Am J Pathol; 2004 Aug; 165(2):501-10. PubMed ID: 15277224
[TBL] [Abstract][Full Text] [Related]
28. Interaction of a Triantennary Quinoline Glycoconjugate with the Asialoglycoprotein Receptor.
Palit S; Banerjee S; Mahata T; Niyogi S; Das T; Sova Mandi C; Chakrabarti P; Dutta S
ChemMedChem; 2021 Jul; 16(14):2211-2216. PubMed ID: 33860988
[TBL] [Abstract][Full Text] [Related]
29. Radiosynthesis and biological evaluation of an fluorine-18 labeled galactose derivative [
Sun P; Zhu Y; Han Y; Hu K; Huang S; Wang M; Wu H; Tang G
Bioorg Med Chem Lett; 2020 Jun; 30(12):127187. PubMed ID: 32307237
[TBL] [Abstract][Full Text] [Related]
30. Efficient delivery of paclitaxel into ASGPR over-expressed cancer cells using reversibly stabilized multifunctional pullulan nanoparticles.
Huang L; Wang Y; Ling X; Chaurasiya B; Yang C; Du Y; Tu J; Xiong Y; Sun C
Carbohydr Polym; 2017 Mar; 159():178-187. PubMed ID: 28038747
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor.
Meier M; Bider MD; Malashkevich VN; Spiess M; Burkhard P
J Mol Biol; 2000 Jul; 300(4):857-65. PubMed ID: 10891274
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugs.
Jain A; Jain A; Parajuli P; Mishra V; Ghoshal G; Singh B; Shivhare US; Katare OP; Kesharwani P
Drug Discov Today; 2018 May; 23(5):960-973. PubMed ID: 29129804
[TBL] [Abstract][Full Text] [Related]
33. Cell Type-Specific Delivery of RNAi by Ligand-Functionalized Curdlan Nanoparticles: Balancing the Receptor Mediation and the Charge Motivation.
Wu Y; Cai J; Han J; Baigude H
ACS Appl Mater Interfaces; 2015 Sep; 7(38):21521-8. PubMed ID: 26345600
[TBL] [Abstract][Full Text] [Related]
34. An internalizing antibody specific for the human asialoglycoprotein receptor.
Trahtenherts A; Benhar I
Hybridoma (Larchmt); 2009 Aug; 28(4):225-33. PubMed ID: 19663694
[TBL] [Abstract][Full Text] [Related]
35. Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes.
Yang D; Zheng X; Wang N; Fan S; Yang Y; Lu Y; Chen Q; Liu X; Zheng J
Oncotarget; 2016 Sep; 7(36):57498-57513. PubMed ID: 27542278
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte behavior on synthetic glycopolymer matrix: inhibitory effect of receptor-ligand binding on hepatocyte spreading.
Kim SH; Hoshiba T; Akaike T
Biomaterials; 2004 May; 25(10):1813-23. PubMed ID: 14738845
[TBL] [Abstract][Full Text] [Related]
37. Complement-mediated cytotoxicity and inhibition of ligand binding to hepatocytes by woodchuck hepatitis virus-induced autoantibodies to asialoglycoprotein receptor.
Diao J; Churchill ND; Michalak TI
Hepatology; 1998 Jun; 27(6):1623-31. PubMed ID: 9620336
[TBL] [Abstract][Full Text] [Related]
38. Novel synthetic LPDs consisting of different cholesterol derivatives for gene transfer into hepatocytes.
Lu J; Zhu D; Zhang ZR; Hai L; Wu Y; Sun X
J Drug Target; 2010 Aug; 18(7):520-35. PubMed ID: 20067439
[TBL] [Abstract][Full Text] [Related]
39. N-Acetylgalactosamine Block-co-Polycations Form Stable Polyplexes with Plasmids and Promote Liver-Targeted Delivery.
Dhande YK; Wagh BS; Hall BC; Sprouse D; Hackett PB; Reineke TM
Biomacromolecules; 2016 Mar; 17(3):830-40. PubMed ID: 26854615
[TBL] [Abstract][Full Text] [Related]
40. Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR).
Zhang Y; Zhang X; Zeng C; Li B; Zhang C; Li W; Hou X; Dong Y
Bioorg Med Chem; 2019 Jun; 27(11):2187-2191. PubMed ID: 31005367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
